Billancourt, France

Sentob Saragosti


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 13(Granted Patents)


Location History:

  • Boulogne-Billancourt, FR (2000 - 2001)
  • Billancourt, FR (2003 - 2012)

Company Filing History:


Years Active: 2000-2012

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Sentob Saragosti in HIV Research

Introduction

Sentob Saragosti, an accomplished inventor based in Billancourt, France, has made significant contributions to the field of HIV research. With a total of six patents to his name, his work focuses on unique strains and diagnostic methods that advance our understanding of HIV-1.

Latest Patents

Among his latest innovations, Sentob Saragosti has developed patents related to Non-M, non-O HIV-1 strains and their fragments. These include a specific strain designated as YBF30, which has potential applications as both a diagnostic reagent and an immunogenic agent. Additionally, he has worked on retroviral strains that differ from both the M group and the O group, enhancing the landscape of HIV diagnostics and treatments.

Career Highlights

Sentob's career has been marked by his tenure at prestigious institutions. He has been associated with the Institut National De La Santé Et De La Recherche Médicale (Inserm) and Assistance Publique-Hôpitaux De Paris. His contributions in these environments have been pivotal in advancing medical research and innovation in the field of infectious diseases.

Collaborations

Throughout his career, Sentob Saragosti has collaborated with notable researchers in his field. Among his coworkers are Ibtissam Loussert-Ajaka and Philippe Mauclere, both of whom have greatly contributed to the ongoing research efforts in HIV and related fields.

Conclusion

Sentob Saragosti stands out as a significant inventor in the realm of HIV research. His innovative patents, combined with his extensive career in reputable institutions and collaborations with other experts, highlight his commitment to advancing medical science and improving diagnostic practices for HIV-1.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…